A

Artiva Biotherapeutics

72 employees

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
cell therapy
nk cell therapy
Therapeutics
nk cells
cancer
car-nk
Life Science

Date founded

2019

Funding rounds raised

Total raised

$120M

from 10 investors over 10 rounds

A

Artiva Biotherapeutics raised $120M on February 26, 2021

Investors: RA Capital Management, L.P., RTW Investments, LP, Wellington Management, Surveyor Capital, venBio Partners and Logos Global Management, LP

A

Artiva Biotherapeutics raised $78M on June 26, 2020

Investors: Medivate Partners, RA Capital Management, L.P., venBio Partners and 5AM Ventures

FAQ